A novel flow cytometry-based cell capture platform for the detection, capture and molecular characterization of rare tumor cells in blood

BACKGROUND: Personalized cancer treatment relies on the accurate detection of actionable genomic aberrations in tumor cells. Circulating tumor cells (CTCs) could provide an alternative genetic resource for diagnosis; however, the technical difficulties in isolating and analyzing rare CTCs have limit...

Descripción completa

Detalles Bibliográficos
Autores principales: Watanabe, Masaru, Serizawa, Masakuni, Sawada, Takeshi, Takeda, Kazuo, Takahashi, Toshiaki, Yamamoto, Nobuyuki, Koizumi, Fumiaki, Koh, Yasuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Methodology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053587/
https://www.ncbi.nlm.nih.gov/pubmed/24886394
http://dx.doi.org/10.1186/1479-5876-12-143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053587/
https://www.ncbi.nlm.nih.gov/pubmed/24886394
http://dx.doi.org/10.1186/1479-5876-12-143

Ejemplares similares